06955 BOAN BIOTECH
Trading Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 1.47X | Oper Margin | 14.6% |
---|---|---|---|
LT Debt/Equity | 26.1% | Net Margin | 10.1% |
Total Debt/Equity | 41.7% | Return on Equity | 4.5% |
Price/Book | 5.08X | Return on Assets | 2.6% |
(HKD 16.580) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | 77.84 | -131.58 | -371.96 | -275.71 | -285.47 |
---|---|---|---|---|---|
Net Profit Growth (%) | +159.2 | +64.6 | -34.9 | +3.4 | N/A |
Earnings Per Share (HKD) | 0.145 | -0.258 | -0.746 | -0.576 | -7.277 |
Earnings Per Share Growth (%) | +156.2 | +65.4 | -29.5 | +92.1 | N/A |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | 114.19 | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 3.262 | 2.857 | 3.123 | N/A | N/A |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 726.316 | 618.129 | +17.5 | 515.96 |
Operating Result | 73.189 | -119.377 | -161.3 | -331.749 |
Profit Before Taxation | 73.189 | -119.377 | -161.3 | -331.749 |
Profit /( Loss) After Taxation | 73.189 | -119.377 | -161.3 | -331.749 |
Net Profit | 73.189 | -119.377 | -161.3 | -331.749 |
Earnings Per Share () | 0.1452 | -0.2584 | -156.2 | -0.7460 |
Announcement Date | 2025-03-27 | 2024-03-25 | NA | 2023-03-27 |
* Annualised
Last Update Time: 2025-07-22 21:40:25